CONTACT US
Processes
Procedures
Equipment
In place to create customer-specific recipes for fast tech transfers
KojoX is optimized manufacturing platforms
We offer flexible production capacity based on optimum combination of Single-use and Stainless-steel technologies
Small 2 x 500 L
Single-Use Systems and Hybrid
Medium 4 x 2K L
Single-Use Systems and Hybrid
Large 6 x 2K L or 2 x 3K L (MB)
Single-Use Systems and Hybrid
4 Pack 4 x 20,000 L
Stainless Steel
KojoX is a new level of global integration
KojoX is fast, efficient and reliable Tech Transfers across the FDB network
Supported through
our global platform management
Texas, United States
1 x 6 Pack
Holly Springs, United States
2 x 4 Pack
Denmark
2 x 4 Pack
2 x 1.5 Pack
FUJIFILM Diosynth Biotechnologies selected the capital investment project previously announced for the Billingham, UK, site for the first application of the KojoX operational model in the single-use network to meet customers’ demands. This flexible single-use cell culture facility is scheduled to be operational in 2026.
As your true Partner for Life, you can trust us to protect your assets as if they are our own.
Our single-use network, with locations in the US and UK, supports our partners’ needs to expedite the delivery of life-impacting therapeutics.
With our global network (US, UK and Denmark) we minimize risks associated with geopolitical challenges.
The harmonized processes and procedures enable seamless tech transfer for clinical and commercial scales between our single-use facilities as well as to our high-capacity network.
Standard process modules provide consistent procedures for tech transfers, facilitating the creation of client-specific recipes improving speed and efficiencies.
KojoX combines the advantages of the required technologies, standardized procedures, and the support of our skilled team of experts to ensure unprecedented delivery of high-quality, life-impacting medicines.
This modular approach, applied across our network, is expected to improve time-to-market, supply resilience, and geographic diversity of supply – aiming to provide fast access to localized manufacturing capacity.
This flexible, modular design provides adaptability to scale out and scale up for rapidly changing market demands.
Applying this philosophy, the facility can be capably equipped with modules of 2,000 L and 5,000 L single-use bioreactors for Mammalian cell culture to be operational in April 2026.
The KojoX framework of standardized tech transfer processes is expected to enable faster time to manufacture for our customers.
Our high-capacity facilities in Denmark and the US support end-to-end partners with late-phase and commercial production needs.
Contact us to learn more about our single-use services and how we can accommodate your development and manufacturing needs.
Introducing the 1st KojoX™ Flexible Cell Culture Facility – in the UK
Hillerød, Denmark
Billingham, UK
Wilton, UK
Darlington, UK
Watertown, MA, USA
Holly Springs, NC, USA
RTP, NC USA
College Station, TX, USA
Thousand Oaks, CA, USA
KojoX, a uniform operating philosophy, when applied across sites, scales and modalities, harmonizes facility layout and design, equipment, processes and procedures through modular concepts to help our customers’ molecules progress through the regulatory process quickly and efficiently to improve patient access to medicines.
Click on boxes below to learn more
Click to learn more
Click on the map to see our locations
Standardized and flexible equipment configurations put the customer in charge with fit-for-purpose modules providing fast, low-risk / well-known solutions
Ensure high quality cGxP process execution grounded in experience and expertise